MEGAN WIESEL: Open Payments
NPI 1528060225 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,787 in 197 payments from 22 companies in 2025. Trend: 2023 $3,684 · 2024 $4,724 · 2025 $4,787
Food & beverage: $3,381Honoraria: $1,200Education: $206
| Company | Payments | Amount |
|---|---|---|
| LNHC, Inc | 1 | $1,200 |
| Janssen Biotech, Inc. | 22 | $475 |
| UCB, Inc. | 12 | $425 |
| Arcutis Biotherapeutics, Inc. | 40 | $421 |
| GENZYME CORPORATION | 10 | $394 |
| ABBVIE INC. | 25 | $314 |
| LEO Pharma Inc. | 12 | $281 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $239 |
| Incyte Corporation | 11 | $222 |
| PFIZER INC. | 15 | $138 |
Products named: ZELSUVMI, DUPIXENT, TREMFYA, Bimzelx, Zoryve, OPZELURA, SKYRIZI, ANZUPGO.
Industry payments across NV — which companies pay providers there.
